These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24494530)

  • 21. Circulating pemphigus IgG in families of patients with pemphigus: comparison of indirect immunofluorescence, direct immunofluorescence, and immunoblotting.
    Brandsen R; Frusic-Zlotkin M; Lyubimov H; Yunes F; Michel B; Tamir A; Milner Y; Brenner S
    J Am Acad Dermatol; 1997 Jan; 36(1):44-52. PubMed ID: 8996260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and immunological profile of umbilical involvement in pemphigus vulgaris and pemphigus foliaceus.
    Oliveira Júnior JV; Maruta CW; Sousa JX; Santi CG; Valente NY; Ichimura LM; Périgo AM; Aoki V
    Clin Exp Dermatol; 2013 Jan; 38(1):20-4. PubMed ID: 23083306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of seropositivity against infectious agents amongst pemphigus vulgaris patients: a case-control study on Strongyloides stercoralis, Helicobacter pylori, Toxoplasma gondii, Leishmania major, and Epstein-Barr virus.
    Mortazavi H; Hejazi P; Khamesipour A; Mohebali M; Ehsani AH; Mohammadi Y; Farahani IV; Amirzargar AA
    Int J Dermatol; 2015 Nov; 54(11):e458-65. PubMed ID: 26175264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pemphigus erythematosus. Presentation of four cases and review of literature.
    Amerian ML; Ahmed AR
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 1):215-22. PubMed ID: 6371067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
    Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
    Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-desmoglein-1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximab.
    Balighi K; Sakhi RS; Daneshpazhooh M; Mahmoudi H; Teimourpour A; Tavakolpour S
    Dermatol Ther; 2018 Nov; 31(6):e12671. PubMed ID: 30246907
    [No Abstract]   [Full Text] [Related]  

  • 28. Neonatal pemphigus vulgaris.
    Merlob P; Metzker A; Hazaz B; Rogovin H; Reisner SH
    Pediatrics; 1986 Dec; 78(6):1102-5. PubMed ID: 3537950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development?
    Torzecka JD; Woźniak K; Kowalewski C; Waszczykowska E; Sysa-Jedrzejowska A; Pas HH; Narbutt J
    Arch Dermatol Res; 2007 Aug; 299(5-6):239-43. PubMed ID: 17534636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
    Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgaris.
    Nagel A; Podstawa E; Eickmann M; Müller HH; Hertl M; Eming R
    J Invest Dermatol; 2009 Sep; 129(9):2202-10. PubMed ID: 19282839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission.
    Daneshpazhooh M; Zafarmand Sedigh V; Balighi K; Hosseini SH; Ramezani A; Kalantari MS; Ghandi N; Ghiasi M; Nikoo A; Chams-Davatchi C
    J Am Acad Dermatol; 2016 Jun; 74(6):1160-5. PubMed ID: 26896293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunopathologic and histologic studies on skin from pemphigus patients in tissue culture.
    Chorzelski TP; Rogozinski T; Sulej J
    J Cutan Pathol; 1979 Apr; 6(2):130-3. PubMed ID: 383751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature.
    Shinkuma S; Nishie W; Shibaki A; Sawamura D; Ito K; Tsuji-Abe Y; Natsuga K; Chan PT; Amagai M; Shimizu H
    Clin Exp Dermatol; 2008 Nov; 33(6):724-8. PubMed ID: 18627395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of herpetiform pemphigus with anti-desmoglein 3 IgG autoantibodies.
    Isogai R; Kawada A; Aragane Y; Amagai M; Tezuka T
    J Dermatol; 2004 May; 31(5):407-10. PubMed ID: 15187309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives.
    Kricheli D; David M; Frusic-Zlotkin M; Goldsmith D; Rabinov M; Sulkes J; Milner Y
    Br J Dermatol; 2000 Aug; 143(2):337-42. PubMed ID: 10951142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case of pemphigus with immunoglobulin G and A antibodies, binding to both the intercellular spaces and basement membrane zone.
    Hosoda S; Adachi A; Suzuki M; Yamada T; Komine M; Murata S; Ohtsuki M
    J Dermatol; 2016 Feb; 43(2):194-6. PubMed ID: 26219735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of pemphigus autoantibodies by IIF and ELISA tests in patients with pemphigus vulgaris and foliaceus and in healthy relatives.
    Torzecka JD; Narbutt J; Sysa-Jedrzejowska A; Waszczykowska E; Lukamowicz J; Pas HH
    Med Sci Monit; 2003 Dec; 9(12):CR528-33. PubMed ID: 14646976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris.
    Bystryn JC; Jiao D
    Autoimmunity; 2006 Nov; 39(7):601-7. PubMed ID: 17101504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.